ASG Superconductors and researchers from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) in Germany have revealed that they plan to develop a prototype of a device that tracks moving tumors with MRI in real-time during proton therapy.
The plan consists of combining a rotating open MRI device (developed by ASG and designed for use with the Linac MRI system at Alberta Health Services in Canada) with a proton beam device at OncoRay, the Dresden, Germany-based National Center for Radiation Research in Oncology. The MRI device uses ASG's helium-free superconducting magnesium diboride (MgB2) magnet and allows for synchronization of the proton beam with tumor motion during the radiation therapy, ASG Superconductors said.
